serena williams ro glp 1 weight loss drug: Tennis star says GLP-1 injections through helped her lose 31 pounds Serena Williams to promote weight-loss

According to a 2025 RAND report, almost 12 percent of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64

is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus, Ozempic and Wegovy

Moreover, functional outcomes, including muscle strength, gait speed and disability falls, should be adopted as primary endpoints rather than secondary measures to ensure meaningful clinical translation

The safest peptide options for women guide discusses tolerance considerations that often favor lower maintenance doses, and the peptides for men guide covers male-specific factors in dose selection

5, 2025), and Medical Chemical Corporation (July 9, 2025)